These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

795 related articles for article (PubMed ID: 20179432)

  • 1. Uterine smooth muscle tumors other than the ordinary leiomyomas and leiomyosarcomas: a review of selected variants with emphasis on recent advances and unusual morphology that may cause concern for malignancy.
    Ip PP; Tse KY; Tam KF
    Adv Anat Pathol; 2010 Mar; 17(2):91-112. PubMed ID: 20179432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathologic considerations of uterine smooth muscle tumors.
    Prayson RA; Hart WR
    Obstet Gynecol Clin North Am; 1995 Dec; 22(4):637-57. PubMed ID: 8786875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uterine smooth-muscle tumors with unusual growth patterns.
    Vaquero ME; Magrina JF; Leslie KO
    J Minim Invasive Gynecol; 2009; 16(3):263-8. PubMed ID: 19423058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bcl-2 receptor expression in patients with uterine smooth muscle tumors: an immunohistochemical analysis comparing leiomyoma, uterine smooth muscle tumor of uncertain malignant potential, and leiomyosarcoma.
    Bodner K; Bodner-Adler B; Kimberger O; Czerwenka K; Mayerhofer K
    J Soc Gynecol Investig; 2004 Apr; 11(3):187-91. PubMed ID: 15051039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous leiomyomatosis of the uterus with pulmonary metastases or a case with benign metastasizing leiomyoma?
    Bodner-Adler B; Bartl M; Wagner G
    Anticancer Res; 2009 Feb; 29(2):495-6. PubMed ID: 19331193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uterine smooth muscle tumors of uncertain malignant potential and atypical leiomyoma: a morphological study of these grey zones with clinical correlation.
    Deodhar KK; Goyal P; Rekhi B; Menon S; Maheshwari A; Kerkar R; Tongaonkar HB
    Indian J Pathol Microbiol; 2011; 54(4):706-11. PubMed ID: 22234095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epithelioid smooth muscle tumors of the uterus do not express CD1a: a potential immunohistochemical adjunct in their distinction from uterine perivascular epithelioid cell tumors.
    Fadare O; Liang SX
    Ann Diagn Pathol; 2008 Dec; 12(6):401-5. PubMed ID: 18995203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic criteria for uterine smooth muscle tumors: leiomyoma variants associated with malignant behavior.
    Giuntoli RL; Gostout BS; DiMarco CS; Metzinger DS; Keeney GL
    J Reprod Med; 2007 Nov; 52(11):1001-10. PubMed ID: 18161397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathology, cytogenetics and molecular biology of uterine leiomyomas and other smooth muscle lesions.
    Quade BJ
    Curr Opin Obstet Gynecol; 1995 Feb; 7(1):35-42. PubMed ID: 7742513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathology of uterine leiomyosarcomas and smooth muscle tumours of uncertain malignant potential.
    Ip PP; Cheung AN
    Best Pract Res Clin Obstet Gynaecol; 2011 Dec; 25(6):691-704. PubMed ID: 21865091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smooth muscle neoplasms of the urinary bladder: a clinicopathologic study of 51 cases.
    Lee TK; Miyamoto H; Osunkoya AO; Guo CC; Weiss SW; Epstein JI
    Am J Surg Pathol; 2010 Apr; 34(4):502-9. PubMed ID: 20154594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MIB-1 (Ki-67), p53, estrogen receptor, and progesterone receptor expression in uterine smooth muscle tumors.
    Mittal K; Demopoulos RI
    Hum Pathol; 2001 Sep; 32(9):984-7. PubMed ID: 11567229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Histological diagnosis and clinical features in borderline smooth muscle tumors of the uterus].
    Shi YF; Xie X; Zhao CL
    Zhonghua Fu Chan Ke Za Zhi; 1994 Apr; 29(4):201-4, 251. PubMed ID: 8082439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MED12 exon 2 mutations in uterine and extrauterine smooth muscle tumors.
    Schwetye KE; Pfeifer JD; Duncavage EJ
    Hum Pathol; 2014 Jan; 45(1):65-70. PubMed ID: 24196187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uterine smooth muscle tumors of uncertain malignant potential (STUMP): a clinicopathologic analysis of 16 cases.
    Ip PP; Cheung AN; Clement PB
    Am J Surg Pathol; 2009 Jul; 33(7):992-1005. PubMed ID: 19417585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphologic features of prognostic significance in uterine smooth muscle tumors: a review of eighty-four cases.
    Burns B; Curry RH; Bell ME
    Am J Obstet Gynecol; 1979 Sep; 135(1):109-14. PubMed ID: 474641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary benign metastasizing leiomyoma associated with intravenous leiomyomatosis of the uterus: clinical behavior and genomic changes supporting a transportation theory.
    Lee HJ; Choi J; Kim KR
    Int J Gynecol Pathol; 2008 Jul; 27(3):340-5. PubMed ID: 18580311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Problematic uterine smooth muscle neoplasms. A clinicopathologic study of 213 cases.
    Bell SW; Kempson RL; Hendrickson MR
    Am J Surg Pathol; 1994 Jun; 18(6):535-58. PubMed ID: 8179071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of MED12, HMGA2, and FH alterations reveals molecular variability in uterine smooth muscle tumors.
    Mäkinen N; Kämpjärvi K; Frizzell N; Bützow R; Vahteristo P
    Mol Cancer; 2017 Jun; 16(1):101. PubMed ID: 28592321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous leiomyomatosis of the uterus. A clinicopathological analysis of 16 cases with unusual histologic features.
    Clement PB; Young RH; Scully RE
    Am J Surg Pathol; 1988 Dec; 12(12):932-45. PubMed ID: 3202247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.